Compares treatment options for Kidney Stones
Official title ILY Robotic System vs Manual Flexible Ureteroscopy for Kidney Stone Treatment
ClinicalTrials.gov ID: NCT06996587
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the efficacy, ergonomics, and safety of robotic versus manual flexible ureteroscopy (fURS) for kidney stone treatment in adult patients undergoing laser lithotripsy. Does robotic-assisted lithotripsy using the ILY® robot have the same efficacy as the manual fURS in treating kidney stones?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Males or females ≥ 18 years old
- Patients with a normal pelvicalyceal anatomy
- Patients with renal stone diagnosis confirmed by noncontrast computed tomography regardless of stone size, location, and multiplicity
- ASA score I-III
- Intact mental and cognitive ability to provide informed consent and willingness to participate in the study with 30-day follow-up
You likely can't join if
- Children \< 18 and pregnant women
- Patients with anatomically anomalous kidneys, known case of stricture or stenosis, or recent 3-month history of ureteroscopy (DJ stent placement only...
- Patients in whom stone measurement was not feasible on NCCT or those with concomitant ureteric stones.
- ASA score IV
- Mentally incapacitated patients unable to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Beirut, Lebanon
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beirut, Lebanon. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.